NasdaqGM - Nasdaq Real Time Price USD

ARS Pharmaceuticals, Inc. (SPRY)

Compare
14.29
-0.03
(-0.21%)
At close: January 30 at 4:00:01 PM EST
14.22
-0.07
(-0.49%)
After hours: 7:26:33 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
2,568.00
30.00
1,316.00
5,506.00
17,835.00
Operating Expense
62,962.00
67,550.00
36,832.00
24,960.00
18,304.00
Operating Income
-60,506.00
-67,520.00
-35,516.00
-19,454.00
-469.00
Other Income Expense
11,402.00
13,155.00
834.00
-789.00
-596.00
Pretax Income
-49,104.00
-54,365.00
-34,682.00
-20,243.00
-1,065.00
Net Income Common Stockholders
-49,104.00
-54,365.00
-34,682.00
-20,243.00
-1,065.00
Diluted NI Available to Com Stockholders
-49,104.00
-54,365.00
-34,682.00
-20,243.00
-1,065.00
Basic EPS
-0.50
-0.57
-0.87
-0.22
-0.01
Diluted EPS
-0.50
-0.57
-0.87
-0.22
-0.01
Basic Average Shares
96,619.93
95,215.32
39,956.04
93,770.17
93,770.17
Diluted Average Shares
96,619.93
95,215.32
39,956.04
93,770.17
93,770.17
Total Operating Income as Reported
-60,506.00
-67,520.00
-35,516.00
-19,454.00
-469.00
Total Expenses
63,074.00
67,550.00
36,832.00
24,960.00
18,304.00
Net Income from Continuing & Discontinued Operation
-49,104.00
-54,365.00
-34,682.00
-20,243.00
-1,065.00
Normalized Income
-49,104.00
-54,365.00
-34,542.00
-20,243.00
-1,065.00
EBIT
-60,506.00
-67,520.00
-35,516.00
-19,454.00
-469.00
EBITDA
-60,506.00
-67,520.00
-35,197.00
-19,241.00
-463.00
Reconciled Depreciation
-7,405.00
-6,805.00
319.00
213.00
6.00
Net Income from Continuing Operation Net Minority Interest
-49,104.00
-54,365.00
-34,682.00
-20,243.00
-1,065.00
Total Unusual Items Excluding Goodwill
--
--
-140.00
--
--
Total Unusual Items
--
--
-140.00
--
--
Normalized EBITDA
-60,506.00
-67,520.00
-35,057.00
-19,241.00
-463.00
12/31/2020 - 12/4/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

VRNA Verona Pharma plc
57.24
+4.40%
 
MIST Milestone Pharmaceuticals Inc.
2.0200
+1.00%
 
TVTX Travere Therapeutics, Inc.
21.05
+2.93%
 
AXSM Axsome Therapeutics, Inc.
108.85
+3.53%
 
ARQT Arcutis Biotherapeutics, Inc.
13.67
-0.36%
 
TARS Tarsus Pharmaceuticals, Inc.
51.74
-2.51%
 
BBIO BridgeBio Pharma, Inc.
35.97
-1.34%
 
MDGL Madrigal Pharmaceuticals, Inc.
338.29
+3.66%
 
CYTK Cytokinetics, Incorporated
49.97
+2.71%
 
HRMY Harmony Biosciences Holdings, Inc.
39.54
+1.85%